Share-Based Compensation - RSAs (Details) - $ / shares	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Restricted Stock Units and Restricted Stock Awards
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Balance at the beginning (in shares)	2,106,540	1,291,492
Granted (in shares)	1,863,539	727,424
Vested (in shares)	(331,675)	(27,188)
Forfeited (in shares)	(56,427)	0
Balance at the end (in shares)	3,581,977	1,991,728
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]
Balance at the beginning (in dollars per share)	$ 7.25	$ 10.98
Granted (in dollars per share)	0.48	7.09
Vested (in dollars per share)	4.12	7.09
Forfeited (in dollars per share)	6.63	0
Balance at the ending (in dollars per share)	$ 4.03	10.98
RSUs
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Vested (in shares)	(331,675)
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]
Granted (in dollars per share)	$ 0.48	$ 7.09
Employees Earnout Shares
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Balance at the beginning (in shares)	1,417,632	1,602,435
Granted (in shares)	0	0
Vested (in shares)	0	(41,578)
Forfeited (in shares)	(16,568)	0
Balance at the end (in shares)	1,401,064	1,560,857
Medical RSUs
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Balance at the beginning (in shares)	147,470	0
Granted (in shares)	8,317	0
Vested (in shares)	(155,787)	0
Forfeited (in shares)	0	0
Balance at the end (in shares)	0	0